Provided by Tiger Trade Technology Pte. Ltd.

Semiconductor Stocks

6,780.63
+105.061.57%
Number of Gainers:12
Number of Losers:5
Number of Flat:- -
PE:- -
High:6,825.39
Open:6,671.32
Low:6,665.54
Close:6,675.57
Volume:369.89M
Turnover:92.98B
Market Cap:12.62T
Float Cap:12.10T

Loading ...

Micron Technology to Report Fiscal Fourth Quarter Results on September 30, 2026

GlobeNewswire
·
Aug 27

Nvidia Stock Could Get Cheaper After Earnings — But Not How You Think, Says Top Investor

TIPRANKS
·
Aug 27

Investors Don't Seem to Believe Nvidia's Earnings Story

Dow Jones
·
Aug 27

U.S. Earnings Preview: After Market Close Aug. 26

Dow Jones
·
Aug 27

Preview: Nvidia Falls Ahead of Results, Due After the Bell

Reuters
·
Aug 27

Cboe data suggests bullish flow in Qualcomm with shares up 1.49%

TIPRANKS
·
Aug 27

Simon Leopold Offers Warning; Intel Stock (NASDAQ:INTC) Slips

TIPRANKS
·
Aug 27

One Nvidia Risk: Transition to Next-Gen AI Architecture

Dow Jones
·
Aug 27

Nvidia Earnings Meets Jackson Hole: 2 ETF Trades for an AI Boom Facing Higher Rates

Benzinga Earnings
·
Aug 27

Chainlink unlocks DeFi lending for Coinbase tokenized stocks

cryptonews
·
Aug 27

INDEPENDENT BOARD UPDATE ON OFFER

GlobeNewswire
·
Aug 27

Three Numbers to Watch in Nvidia's Earnings Report

Dow Jones
·
Aug 27

Polymarket Odds: Will MRVL, RBRK, WDAY Beat Earnings Tomorrow?

TIPRANKS
·
Aug 27

OpenAI’s Jalapeño Chip Is a Direct Threat to Nvidia’s (NVDA) Pricing Power, Analysts Warn

TIPRANKS
·
Aug 27

Anthropic to Spend $45 Billion to Lease Nscale Compute, Taking Over Project Exited by Microsoft

TradingKey
·
Aug 27

Anthropic Has Agreed to Spend $45 Billion to Rent AI Cloud Computing Power from Nscale’S Data Center Development in West Virginia-Bloomberg News

Reuters
·
Aug 27

Nscale Will Use Nvidia's Vera Rubin Chips, Which Will Start to Come Online Late Next Year, to Meet Anthropic’s Needs- Bloomberg News

THOMSON REUTERS
·
Aug 27

NVIDIA options imply 5.9% move in share price post-earnings

TIPRANKS
·
Aug 27

How Nvidia Blew up Wall Street's Expectations Game

Dow Jones
·
Aug 27

U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer

GlobeNewswire
·
Aug 27